DIPAMP

Monsanto s commercial route to the Parkinson s drug, L-DOPA (3,4-dihydroxyphenylalanine), utilizes an Erlenmeyer azlactone prepared from vanillin. The pioneering research in catalytic asymmetric hydrogenation by William Knowles as exemplified by his reduction of 24 to 25 in 95% ee with the DiPAMP diphosphine ligand was recognized with a Nobel Prize in Chemistry in 2001. ... 

The most effective catalysts for enantioselective amino acid synthesis are coordination complexes of rhodium(I) with 1,5-cyclooctadiene (COD) and a chiral diphosphine such as (JR,jR)-l,2-bis(o-anisylphenylphosphino)ethane, the so-called DiPAMP ligand. The complex owes its chirality to the presence of the trisubstituted phosphorus atoms (Section 9.12). 

The numerous chiral phosphine ligands which are available to date [21] can be subclassified into three major categories depending on the location of the chiral center ligands presenting axial chirality (e.g., BINAP 1 and MOP 2), those bearing a chiral carbon-backbone (e.g., DIOP 3, DuPHOS 4), and those bearing the chiral center at the phosphorus atom (e. g., DIPAMP 5, BisP 6), as depicted in Fig. 1. 

Attempts to prepare optically active amines by replacing dppe with optically active diphosphines such as DIOP or DIPAMP in the Pd/dppe system [183] or by replacing PhP(Oi-Pr)2 with dimenthyl phenylphosphinite in the Ni/PhP(Oi-Pr)2 system [184] have met with little success. 

An especially important case is the enantioselective hydrogenation of a-amidoacrylic acids, which leads to a-aminoacids.29 A particularly detailed study has been carried out on the mechanism of reduction of methyl Z-a-acetamidocinnamate by a rhodium catalyst with a chiral diphosphine ligand DIPAMP.30 It has been concluded that the reactant can bind reversibly to the catalyst to give either of two complexes. Addition of hydrogen at rhodium then leads to a reactive rhodium hydride and eventually to product. Interestingly, the addition of hydrogen occurs most rapidly in the minor isomeric complex, and the enantioselectivity is due to this kinetic preference. 

Early work in the field of asymmetric hydroboration employed norbornene as a simple unsaturated substrate. A range of chiral-chelating phosphine ligands were probed (DIOP (5), 2,2 -bis(diphenyl-phosphino)-l,l -binaphthyl (BINAP) (6), 2,3-bis(diphenylphosphino)butane (CHIRAPHOS) (7), 2,4-bis(diphenylphosphino)pentane (BDPP) (8), and l,2-(bis(o-methoxyphenyl)(phenyl)phos-phino)ethane) (DIPAMP) (9)) in combination with [Rh(COD)Cl]2 and catecholborane at room temperature (Scheme 8).45 General observations were that enantioselectivities increased as the temperature was lowered below ambient, but that variations of solvent (THF, benzene, or toluene) had little impact. 

The five-membered ring chelate ligands (CHIRAPHOS (7) and DIPAMP (9)) showed poor activity. DIOP (5) was found to be more effective than BINAP (6), while no real improvements in the levels of asymmetric induction were found by using cationic complexes [Rh(COD)(L-L)]+ instead of neutral systems. 

Subsequently, Burgess79 prepared a series of hybrid ligands (27a-c) (Figure 3) which were chiral not only in the carbon backbone like (R, R)-DIOP 25 but also at phosphorus, like DIPAMP. 

This achievement was unique in two respects 1) it was the first example of industrial application of a homogeneous enantioselective catalysis methodology and 2) it represented a rare example of very quick convergence of basic knowledge into commercial application. The monophosphine ligand CAMP was shortly replaced by the related diphosphine ligand DIPAMP which improved the selectivity for the I-DOPA system up to 95% ee [45]. 

Fig. 10.22 31P-NMR spectrum of a solution of 0.02 mM [Rh((S,S)-DIPAMP)(MeOH)2]BF4 and 0.1 mM (Z)-2-benzoyl-amino-3-(3,4-dimethoxyphenyl)-methyl acrylate.

---